Doug Hampton LUXEMBOURG, Nov. 10, 2023 /PRNewswire/ — Auna S.A. (“Auna,” the “Company” or “we”), one of the largest players in the Latin American healthcare industry and with presence in Mexico, Colombia and Peru, announced today that it has commenced an offer to Eligible Holders (as defined herein) to exchange (the “Exchange Offer”) any and all of its … Read more
SEONGNAM, South Korea, Nov. 10, 2023 /PRNewswire/ — Rznomics Inc., a South Korea based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, announced today that it has entered into a clinical collaboration agreement with F. Hoffmann-La Roche Ltd (Roche) to study RZ-001, a gene therapy approach utilizing the company’s proprietary trans-splicing ribozyme-based RNA reprogramming and editing … Read more
Meet Huey, the PTSD service dog providing life-changing support for his U.S. Army veteran owner ST. LOUIS, Nov. 9, 2023 /PRNewswire/ — In honor of Veteran’s Day, Purina Dog Chow and award-winning recording artist and actor Anthony Ramos are proud to introduce this year’s Dog Chow Visible Impact Award winner: Huey, a service dog who … Read more
LOS ANGELES, Nov. 8, 2023 /PRNewswire/ — Herbalife and LA Galaxy hosted a Thanksgiving cooking class for more than 70 students from Leapwood Avenue and Annalee elementary schools following a soccer clinic led by LA Galaxy coaching staff. The cooking class was led by Matthew Lindblom, executive chef for Levy Restaurants, and held at the LA … Read more
NEW YORK, Nov. 7, 2023 /PRNewswire/ — The cold plasma market is set to grow by USD 1,790.8 million from 2022 to 2027, progressing at a CAGR of 14.42% during the forecast period. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The increasing demand for eco-friendly … Read more
STOCKHOLM, Nov. 7, 2023 /PRNewswire/ — BioArctic AB’s (publ) (NASDAQ; BIOA B) (Stockholm: BIOA B) partner Eisai today held a presentation on the second quarter of Eisai’s fiscal year, ending March 2024. In addition to presenting sales numbers of 0.4 billion yen for LEQEMBI for the period, Eisai also stated the following; The launch of … Read more
Leading supplement brand debuts the only probiotic toothpaste suitable for sensitive teeth PALM COAST, Fla., Nov. 6, 2023 /PRNewswire/ — Designs for Health, the expert-recommended and preferred brand for high-quality, professional strength, research-backed supplements, and recipient of the 2023 Top Nutraceutical Company award** today announced the launch of PerioBiotic™ Silver, a fluoride-free probiotic toothpaste formulated with … Read more
SHANGHAI, Nov. 4, 2023 /PRNewswire/ — On October 26, 2023, KangaBio announced that the U.S. FDA has granted official approval for their independent R&D clinical trial application (IND) for KGX101. KGX101 is a recombinant IL-12 Fc fusion protein designed for intravenous injection. The KGX101 clinical trials will be carried out simultaneously in both United States … Read more
NEW YORK, Oct. 31, 2023 /PRNewswire/ — The next-generation sequencing market size is forecast to increase by USD 3,409.76 million from 2022 to 2027, at a CAGR of 12.45%, according to the recent market study by Technavio. The growth of the market will be driven by the Increased utilization of NGS methods, Growing demand for early diagnosis of … Read more
ROCKVILLE, Md., Oct. 30, 2023 /PRNewswire/ — REGENXBIO Inc. (Nasdaq: RGNX) today announced presentations at the American Academy of Ophthalmology (AAO) 2023 Annual Meeting being held November 3-6, 2023 in San Francisco, CA. The presentations will highlight new data for ABBV-RGX-314, an investigational one-time AAV Therapeutic being developed in collaboration with AbbVie for the treatment … Read more